Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks ByKaitlyn Bader, Senior Editor ,Loretta Fiorillo, MD, FRCPCApril 9th 2024Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.